Françoise Livio

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


89 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1998 |
Acute ischaemic stroke in active cancer versus non-cancer patients: stroke characteristics, mechanisms and clinical outcomes.
Costamagna G., Hottinger A.F., Milionis H., Salerno A., Strambo D., Livio F., Navi B.B., Michel P., 2024/04. European journal of neurology, 31 (4) pp. e16200. Peer-reviewed.
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data.
Berton M., Bettonte S., Stader F., Decosterd L., Tarr P.E., Livio F., Cavassini M., Braun D.L., Kusejko K., Hachfeld A. et al., 2024/01/25. Clinical infectious diseases, 78 (1) pp. 98-110. Peer-reviewed.
Joint fluid concentrations of amphotericin B after local application with calcium sulphate-report of 2 cases.
Pozzi L., Schläppi M., Livio F., Blatter S., Achermann Y., Wahl P., 2023/11. APMIS, 131 (11) pp. 567-573. Peer-reviewed.
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole.
Haefliger D., Marzolini C., Lamoth F., Pabst T., Buclin T., Livio F., 2023/07. British journal of clinical pharmacology, 89 (7) pp. 2304-2308. Peer-reviewed.
 
Clinical and Demographic Characteristics, Mechanisms, and Outcomes in Patients With Acute Ischemic Stroke and Newly Diagnosed or Known Active Cancer.
Costamagna G., Hottinger A., Milionis H., Lambrou D., Salerno A., Strambo D., Livio F., Navi B.B., Michel P., 2023/06/13. Neurology, 100 (24) pp. e2477-e2489. Peer-reviewed.
 
Pharmacothérapie. Nouveaux médicaments et vaccins disponibles en 2022 [Pharmacotherapy. New drugs and vaccines in 2022]
Haefliger D., Livio F., 2023/01/18. Revue medicale suisse, 19 (N° 809-10) pp. 66-73. Peer-reviewed.
Wound fluid ceftriaxone concentrations after local application with calcium sulphate as carrier material in the treatment of orthopaedic device-associated hip infections.
Wiesli M.G., Livio F., Achermann Y., Gautier E., Wahl P., 2022/11. Bone & joint research, 11 (11) pp. 835-842. Peer-reviewed.
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient.
Girardin F.R., Tzankov A., Pantaleo G., Livio F., Greub G., 2022/05/23. Swiss medical weekly, 152 pp. w30188. Peer-reviewed.
Hyperuricémie et maladie rénale : prise en charge [Management of hyperuricemia in chronic kidney disease]
Schwotzer N., Auberson M., Livio F., So A., Bonny O., 2022/03/02. Revue medicale suisse, 18 (771) pp. 379-384. Peer-reviewed.
Pharmacovigilance - Vaccins à ARNm contre le Covid-19 : le point sur les effets indésirables [Pharmacovigilance - mRNA COVID-19 vaccines : current state of knowledge on their adverse effects]
Favre V., Ekobena P., Chtioui H., Rothuizen L.E., Livio F., Genton B., Buclin T., 2022/02/02. Revue medicale suisse, 18 (767) pp. 190-197. Peer-reviewed.
Prevalence and Factors Associated with Opioid Prescription in Swiss Chronic Hemodialysis Patients
Hennebel Clémence, Vilmont Valérie, Cherpillod Anne, Fumeaux David, Fakhouri Fadi, Livio Françoise, Burnier Michel, Pruijm Menno, 2022/01/02. Kidney and Dialysis, 2 (1) pp. 6-15.
Pembrolizumab-induced massive hypereosinophilia associated with mononeuritis multiplex, brain microvascular lesions and intestinal eosinophilic infiltration in a melanoma patient
Dao Kim, Kuntzer Thierry, Maeder Philippe, Frossard Valerie, Livio Francoise, 2021/12. Current Problems in Cancer: Case Reports, 4 p. 100133.
 
Drugs Associated With Ischemic Stroke: A Review for Clinicians.
Marto J.P., Strambo D., Livio F., Michel P., 2021/10. Stroke, 52 (10) pp. e646-e659. Peer-reviewed.
Médicaments, sexe et genre [Medicines, sex and gender]
Buclin T., Rothuizen L.E., Livio F., 2021/06/30. Revue medicale suisse, 17 (744-2) pp. 1262-1264. Peer-reviewed.
 
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.
Meylan S., Livio F., Foerster M., Genoud P.J., Marguet F., Wuerzner G., CHUV COVID Vaccination Center, 2021/06. Hypertension, 77 (6) pp. e56-e57. Peer-reviewed.
 
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study.
Pauliat E., Onken M., Weber-Schoendorfer C., Rousson V., Addor M.C., Baud D., Théaudin M., Diav-Citrin O., Cottin J., Agusti A. et al., 2021/03. Multiple sclerosis, 27 (3) pp. 475-478. Peer-reviewed.
 
Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity.
Livio F., Deutschmann E., Moffa G., Rrustemi F., Stader F., Elzi L., Braun D.L., Calmy A., Hachfeld A., Cavassini M. et al., 2021/02/11. The Journal of antimicrobial chemotherapy, 76 (3) pp. 758-764. Peer-reviewed.
Pharmacovigilance [Pharmacovigilance update]
Ekobena P., Ivanyuk A., Livio F., 2021/01/13. Revue medicale suisse, 17 (720-1) pp. 80-84. Peer-reviewed.
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.
Ryom L., Cotter A., De Miguel R., Béguelin C., Podlekareva D., Arribas J.R., Marzolini C., Mallon P., Rauch A., Kirk O. et al., 2020/11. HIV medicine, 21 (10) pp. 617-624. Peer-reviewed.
 
Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.
Blum S., Dunet V., Comoli P., Tirefort Y., Chalandon Y., Opota O., Comte D., Spertini O., Livio F., Brouland J.P. et al., 2020/09. Leukemia & lymphoma, 61 (9) pp. 2226-2229. Peer-reviewed.
 
Real-life management of drug-drug interactions between antiretrovirals and statins.
Courlet P., Livio F., Alves Saldanha S., Scherrer A., Battegay M., Cavassini M., Stoeckle M., Decosterd L.A., Marzolini C., Swiss HIV Cohort Study, 2020/07/01. The Journal of antimicrobial chemotherapy, 75 (7) pp. 1972-1980. Peer-reviewed.
Traitements aggravant une infection par le COVID-19 : vraiment ? [Drugs that aggravate the course of COVID-19 : really ?]
Rothuizen L.E., Livio F., Buclin T., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 852-854. Peer-reviewed.
Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV.
Courlet P., Livio F., Guidi M., Cavassini M., Battegay M., Stoeckle M., Buclin T., Alves Saldanha S., Csajka C., Marzolini C. et al., 2019/12. Open forum infectious diseases, 6 (12) pp. ofz531. Peer-reviewed.
 
Prescribing issues in elderly individuals living with HIV.
Marzolini C., Livio F., 2019/07. Expert review of clinical pharmacology, 12 (7) pp. 643-659. Peer-reviewed.
Pharmacovigilance, hémovigilance, vaccinovigilance, tératovigilance… : quelles retombées imprévues pour les patients, les intervenants de santé et les systèmes de soins ?
Buclin Thierry, Foley Rose-Anna, Livio Françoise, 2019/04/11. Anthropologie & Santé.
 
Pharmacovigilance [Pharmacovigilance update]
Abo Loha C., Livio F., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 92-95. Peer-reviewed.
Prescribing issues in older adults living with HIV: thinking beyond drug-drug interactions with antiretroviral drugs.
Livio F., Marzolini C., 2019. Therapeutic advances in drug safety, 10 p. 2042098619880122. Peer-reviewed.
 
Fractures vertébrales multiples à l’arrêt du denosumab: comment les éviter? [Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]
Lamy O., Gonzalez Rodriguez E., Stoll D., Aubry-Rozier B., Livio F., 2018/06. Praxis, 107 (12) pp. 649-654. Peer-reviewed.
 
Pharmacovigilance [Pharmacovigilance update]
Livio F., 2018/01/10. Revue medicale suisse, 14 (588-589) pp. 81-84. Peer-reviewed.
 
Arrêt cardiaque suite à l’administration accidentelle d’amphotéricine B sous forme désoxycholate
Cuda Loredana, Mury Caroline, Pagani Jean-Luc, Revelly Jean-Pierre, Livio Françoise, Aubert John-David, Schaller Marie-Denise, Voirol Pierre, Eggimann Philippe, Que Yok-Ai, 2018. Forum Medical Suisse, 18 (50) pp. 1067-1071. Peer-reviewed.
 
Prescribing issues in the Swiss HIV infected ageing population
Livio F., Rrustemi F., Moffa G., Elzi L., Stader F., Braun D., Calmy A., Hachfeld A., Cavassini M., Tarr P. et al., 2018., 18th International Society of Pharmacovigilance (ISoP) Annual Meeting, Geneva pp. 1252-1253 dans Drug Safety.
 
Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.
Marzolini C., Decosterd L., Winterfeld U., Tissot F., Francini K., Buclin T., Livio F., 2017/12. British journal of clinical pharmacology, 83 (12) pp. 2835-2838. Peer-reviewed.
 
Renal Drug Transporters and Drug Interactions.
Ivanyuk A., Livio F., Biollaz J., Buclin T., 2017/08. Clinical pharmacokinetics, 56 (8) pp. 825-892. Peer-reviewed.
 
Guidance to develop individual dose recommendations for patients on chronic hemodialysis.
Gotta V., Dao K., Rodieux F., Buclin T., Livio F., Pfister M., 2017/07. Expert review of clinical pharmacology, 10 (7) pp. 737-752. Peer-reviewed.
 
Recurrent Asystole After Neostigmine in a Heart Transplant Recipient With End-Stage Renal Disease.
Cachemaille M., Olofsson M., Livio F., Pascale P., Zingg T., Boegli Y., 2017/04. Journal of cardiothoracic and vascular anesthesia, 31 (2) pp. 653-656. Peer-reviewed.
 
Adverse drug reactions as a cause of admission to intensive care unit: a 4-months prospective cohort study
Berthaut V., Renard D., Schaller M.D., Manzon C., Voirol P., Buclin T., Livio F., 2017., 17th International Society of Pharmacovigilance (ISoP) Annual Meeting, Liverpool p. 944 dans Drug Safety.
 
Direct oral anticoagulants: are they safer than vitamin K antagonists?
Baumberger M., Hugli O., Buclin T., Livio F., 2017., 17th International Society of Pharmacovigilance (ISoP) Annual Meeting, Liverpool pp. 943-944 dans Drug Safety.
 
The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material.
Wahl P., Guidi M., Benninger E., Rönn K., Gautier E., Buclin T., Magnin J.L., Livio F., 2017. The Bone & Joint Journal, 99-B (11) pp. 1537-1544. Peer-reviewed.
Sélection de cas issus des centres régionaux de pharmacovigilance
Weiler Stefan, Taegtmeyer Anne B., Müller Sabine, Rollason Victoria, Livio Françoise, Ceschi Alessandro, Kullak-Ublick Gerd A., 2016/09/14. Forum Médical Suisse pp. 757-763.
 
Pharmacovigilance [Pharmacovigilance update]
Dao K., Chtioui H., Rothuizen L.E., Diezi L., Prod'hom S., Winterfeld U., Buclin T., Livio F., 2016/01/13. Revue medicale suisse, 12 (500) pp. 75-79.
 
Pharmacokinetic modelling of dialytic clearance in a case of acyclovir intoxication.
Kissling S., Fuchs A., Gobin N., Vogt B., Burnier M., Decosterd L.A., Buclin T., Livio F., 2015/11. International Journal of Antimicrobial Agents, 45 (3) pp. 325-327. Peer-reviewed.
 
Des doutes insuffisants pour changer nos pratiques
Winterfeld Ursula, Baud David, Panchaud Alice, Rothuizen Laura, Livio Françoise, Stoller Rudolf, Buclin Thierry, 2015/10. Bulletin des médecins suisses, 96 (41) pp. 1494-1495.
 
Pharmacovigilance [Pharmacovigilance update].
Fogarasi Szabo N., Diezi L., Delenclos L., Renard D., Chtioui H., Rothuizen L.E., Buclin T., Livio F., 2015/01. Revue Médicale Suisse, 11 (456-457) pp. 124-128.
 
Atteintes tendineuses multiples sous traitement de statines : rapport de cas et revue de la litterature
Renard Delphine, Livio Françoise, 2014/10. Forum Medical Suisse, 14 (43) pp. 805-807.
 
Caractérisation du profil pharmacocinétique de la vancomycine chez des patients hospitalisés en médecine générale et chirurgie
Ribeiro J., Cerruti J., Widmer N., Livio F., Buclin T., Csajka C., Guidi M., 2014. dans 2e Congrès Suisse des Pharmaciens.
Is HLA-A*3101 screening cost-effective for preventing carbamazepine-induced severe toxidermia?
Decollogny Anne, Pinget Christophe, Rossetti Andrea, Buclin Thierry, Livio Françoise, 2014. dans European and Swiss Congress of Internal Medicine.
 
Pharmacologie orthopédique
Livio F., Renard D., Senn L., Buclin T., 2014. pp. 35-70 dans Jolles-Haeberli B. (eds.) Manuel Pratique de Chirurgie Orthopédique chap. 2, Elsevier Masson.
 
Pharmacovigilance [Pharmacovigilance update].
Diezi L., Renard D., Rothuizen L.E., Livio F., 2014. Revue Médicale Suisse, 10 (412-413) pp. 119-122.
Tobramycin exposure from active calcium sulfate bone graft substitute.
Livio F., Wahl P., Csajka C., Gautier E., Buclin T., 2014. Bmc Pharmacology and Toxicology, 15 (1) p. 12. Peer-reviewed.
 
Abus de psychotropes : médicaments et drogues
Yersin Bertrand, Feiner Adam-Scott, Livio Françoise, 2013. pp. 246-256 dans Médecine d'urgence préhospitalière chap. 30, Editions Médecine & Hygiène .
 
Guide pratique des effets indésirables médicamenteux chez les seniors [Drug-induced adverse events in the elderly: a traveler's guide].
Barez T., Monod S., Livio F., Renard D., 2013. Revue Médicale Suisse, 9 (405) pp. 2054-2058.
 
Imatinib-induced dose-dependent interstitial lung disease successfully switched to nilotinib: a case report with concentration exposure data.
Dao K., Védy D., Lopez J., Staneczek O., Buclin T., Livio F., 2013. International journal of hematology, 97 (2) pp. 299-300.
 
Pharmacovigilance [Pharmacovigilance update].
Livio F., 2013. Revue Médicale Suisse, 9 (368) pp. 72-75.
 
Urgence préhospitalière. Abus de psychotropes: médicaments et drogues [Prehospital emergency. Abuse of psychotropics: medicines and drugs].
Yersin B., Feiner A.S., Livio F., 2013. Revue Médicale Suisse, 9 (406) pp. 2120-2129.
 
Agents anti-infectieux et fonction réna!e: vers des posologies sur mesure [Antimicrobial agents and renal elimination: towards individual dosage adjustment?].
Willi-Robatel C., Senn L., Livio F., Zanetti G., Marchetti O., Buclin T., 2012. Revue Médicale Suisse, 8 (338) pp. 894-900.
 
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.
Aouri M., Decosterd L.A., Buclin T., Hirschel B., Calmy A., Livio F., 2012. AIDS, 26 (6) pp. 776-778.
 
Efavirenz in an obese HIV-infected patient – a report and an in vitro–in vivo extrapolation model indicate risk of underdosing
de Roche Mirjam, Siccardi Marco, Stoeckle Marcel, Livio Françoise, Back David, Battegay Manuel, Marzolini Catia, 2012. Antiviral therapy, 17 (7) pp. 1381-1384. Peer-reviewed.
 
Pharmacovigilance [Pharmacovigilance].
Livio F., Renard D., Buclin T., 2012. Revue Médicale Suisse, 8 (324) pp. 116-119.
 
Syndrome sérotoninergique: mise au point et revue des cas annoncés en Suisse [Serotonin syndrome: review and case series from the Swiss pharmacovigilance system].
Chassot M., Munz T., Livio F., Buclin T., 2012. Revue Médicale Suisse, 8 (360) pp. 2086-2090.
Utilisation des laxatifs à l'Hôpital
Dao Kim, Renard Delphine, Livio Françoise, Buclin Thierry, De Giorgi I, 2012. GSASA Journal 26 pp. 27-31.
 
Vancomycin exposure from active calcium sulfate bone filler
Livio F., Guidi M., Wahl P., Gautier E., Prod'Hom G., Buclin T., Csajka T., 2012. pp. 112S dans 80. Jahrestagung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
 
Cholelithiasis: obesity complication or orlistat adverse reaction?
Melnikova Martinez-Esteve A., Genin B., Livio F., Produit S., Cheseaux J.J., Llor J., Marcoz J., Tabin R., 2011., Congrès commun des Sociétés suisses de Pédiatrie, Chirurgie pédiatrique, Psychiatrie et Psychothérapie d'enfants et d'adolescents, Montreux pp. 31S dans Swiss Medical Weekly.
 
Pharmacovigilance [Pharmacovigilance update].
Livio F., Biollaz J., Buclin T., 2011. Revue Médicale Suisse, 7 (277) pp. 71-74.
 
Systemic exposure to tobramycin after local antibiotic treatment with calcium sulphate as carrier material.
Wahl P., Livio F., Jacobi M., Gautier E., Buclin T., 2011. Archives of Orthopaedic and Trauma Surgery, 131 (5) pp. 657-662.
 
Traitements de fer: preuves de l'efficacité et bonne pratique clinique [Iron therapy: proof of efficacy and good clinical practice].
Renard D., Favrat B., Livio F., Buclin T., 2011. Revue Médicale Suisse, 7 (292) pp. 923-927.
 
Pharmacovigilance update [Pharmacovigilance update]
Livio F., Ivanyuk A., Biollaz J., Rothuizen L., Buclin T., 2010. Revue Médicale Suisse, 6 (232) pp. 128-131.
 
Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.
Grouzmann E., Livio F., Buclin T., 2009. Hypertension, 54 (3) pp. 468-470. Peer-reviewed.
 
Méthylphénidate et abus
Livio F., Rauber-Lüthy C., Biollaz J., Holzer L., Winterfeld U., Buclin T., 2009. Paediatrica : Bulletin der Schweizerischen Gesellschaft für Pädiatrie (SGP) = Bulletin de la Société suisse de pédiatrie (SSP), 20 (5) pp. 41-44.
 
Pharmacodynamic interaction between SSR180575 and enalapril on the blood pressure response to angiotensin-I challenges in healthy normotensive male volunteers
Livio F., Buclin T., Nussberger J., Appenzeller M., Gaud C., Duluc M.E., Pinquier J.L., Biollaz J., 2009., Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Edinburgh p. 83 dans Basic and Clinical Pharmacology and Toxicology.
 
Pharmacovigilance et teratovigilance 2008 [Pharmacovigilance and teratovigilance 2008]
Livio F., Ivanyuk A., Biollaz J., 2009. Revue Médicale Suisse, 5 (186) pp. 130-134.
 
Estimation de la fonction rénale par l'equation MDRD: intérêt et limites pour l'adaptation des doses de médicaments [Renal function estimation by MDRD equation: interest and limitations for drug dosing].
Livio F., Biollaz J., Burnier M., 2008. Revue Médicale Suisse, 4 (181) pp. 2596-2600.
 
Pharmacovigilance [Pharmacovigilance update]
Livio F., Buclin T., Biollaz J., 2008. Revue Médicale Suisse, 4 (140) pp. 150-154.
 
Pharmacovigilance [Pharmacovigilance update]
Livio F., Buclin T., Biollaz J., 2008. Revue Médicale Suisse, 4 (140) pp. 150-154.
 
Pharmacovigilance et tératovigilance
Livio F., Buclin T., Biollaz J., 2007/01. Revue médicale suisse, 3 (95) pp. 238-242.
 
Generiques et article 38a OPAS: quel impact? [Generic drugs and legal incentives: which impact?]
Livio F., Buclin T., Pannatier A., Biollaz J., 2006/04. Revue Médicale Suisse, 2 (61) pp. 966-9.
 
Pharmacovigitance--pharmaco-epidemiologie. [Trends in drug therapy]
Livio F., Buclin T., Biollaz J., 2006/01. Revue Médicale Suisse, 2 (48) pp. 155-9.
 
Safety of enzyme replacement therapy
Barbey F., Livio F., 2006. pp. 395-404 dans Mehta A.B., Beck M., Sunder-Plassmann G. (eds.) Fabry Disease: Perspectives from 5 Years of FOS chap. 41, Oxford PharmaGenesis.
 
Anaphylactic reaction and unrelated, subsequent, known side effects during therapy with thiethylperazine.
Rossetti G., Livio F., Roulet E., Hofer M.F., 2005/08. Pediatric allergy and immunology, 16 (5) pp. 453-455. Peer-reviewed.
 
Douleurs abdominales et ictere cholestatique recidivant. [Abdominal pain and recurrent cholestatic jaundice]
Livio Ndiaye F., Wiesel P. H., Goy J. J., Genton A., 2004/06. Schweizerische Rundschau fur Medizin Praxis, 93 (24) pp. 1051-4.
Acquired hemophilia as first manifestation of breast carcinoma in a man under long-term spironolactone therapy.
Lamy O., Elmiger H., Fiche M., Bauer J., Livio F., 2004/04. International Journal of Clinical Oncology / Japan Society of Clinical Oncology, 9 (2) pp. 130-133. Peer-reviewed.
 
Acute rhinosinusitis : a pharmacoeconomic review of antibacterial use
Wasserfallen J. B., Livio F., Zanetti G., 2004. Pharmacoeconomics, 22 (13) pp. 829-37. Peer-reviewed.
 
Hyponatrémie: une histoire en deux temps... [Hyponatremia: an unusual case report]
Berwert L., Kaeser P., Livio F., Vollenweider P., Waeber G., 2003. Praxis, 92 (41) pp. 1727-32.
 
Transplantation et goutte .
Livio Ndiaye F, Dudler J, 2003. Médecine et Hygiène pp. 2099-2104.
 
Prévention et traitement de l'insuffisance rénale aiguë : rôle des traitements diurétiques
Livio F., 2002. Médecine et Hygiène, 60 (2387) pp. 727-730.
 
Rate, type, and cost of adverse drug reactions in emergency department admissions.
Wasserfallen J., Livio F., Buclin T., Tillet L., Yersin B., Biollaz J., 2001. European Journal of Internal Medicine, 12 (5) pp. 442-447.
 
Wegener's granulomatosis: description of a case where cutaneous involvement was correlated with elevation of the c-ANCA titer
Mock M., Cerottini J. P., Derighetti M., Buxtorf K., Livio F., Panizzon R. G., 2001. Dermatology, 202 (4) pp. 347-9.
 
Intoxication au lithium
Livio F., Wauters J.P., 2000. Médecine et Hygiène, 58 (2289) pp. 426-430.
 
Les intoxications médicamenteuses volontaires
Buclin T., Livio F., Yersin B., Biollaz J., 2000. pp. 113-119 dans L'abus de médicaments en Suisse chap. 11, SFA-ISPA PRESS, Lausanne.
Hospitalisations pour effet indésirable médicamenteux: recensement prospectif dans un Service d'urgences médicales.
Livio Françoise, Buclin Thierry, Yersin Bertrand, Maghraoui Ali, Burnand Bernard, Biollaz Jérôme, 1998. 129 (Raisons de santé ; 23), Lausanne: CHUV, Division de pharmacologie clinique : Institut universitaire de médecine sociale et préventive (IUMSP).
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University